Notice for tagraxofusp (A Menarini Australia Pty Ltd)
Active ingredients
tagraxofusp
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Concentrate for infusion
Indication
For the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Therapeutic area
Haematology